Health analysis for MapleMyst's Little Brown Jug

Print
Please note: If no health information is shown for an animal, this does not necessarily mean that the animal is healthy but merely that no information was provided.
Date of birth Year of death Cause of death Canine Multifocal Retinopathy 3 (CMR3) Degenerative myelopathy (DM) Elbows Glycogen storage disease type II (Pompe disease) (GSDII) Hips Progressive retinal atrophy (prcd-PRA) Result of general cardiovascular health checks
Parents
28 Oct 2016
0 (null yrs)
N/N (clear) N/N (clear) normal N/N (clear) Good / A2 / 1-3 / A / 5-10 (no >6/hip) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Elbows: normal
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Hips: Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
5 Jan 2018
0 (null yrs)
N/N (clear) N/N (clear) normal N/N (clear) Good / A2 / 1-3 / A / 5-10 (no >6/hip) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Elbows: normal
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Hips: Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
Siblings
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) normal N/N (clear) Good / A2 / 1-3 / A / 5-10 (no >6/hip) N/N (clear) OK
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Elbows: normal
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Hips: Good / A2 / 1-3 / A / 5-10 (no >6/hip)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
Result of general cardiovascular health checks: OK
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
29 Sep 2020
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
Half siblings (sire)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
19 May 2019
0 (null yrs)
N/N (clear) N/N (clear) N/N (clear) N/N (clear)
Canine Multifocal Retinopathy 3 (CMR3): N/N (clear)
Degenerative myelopathy (DM): N/N (clear)
Glycogen storage disease type II (Pompe disease) (GSDII): N/N (clear)
Progressive retinal atrophy (prcd-PRA): N/N (clear)
Half siblings (dam)
Offspring